A detailed history of Stone X Group Inc. transactions in Amgen Inc stock. As of the latest transaction made, Stone X Group Inc. holds 13,538 shares of AMGN stock, worth $4.28 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
13,538
Previous 12,677 6.79%
Holding current value
$4.28 Million
Previous $3.6 Million 17.37%
% of portfolio
0.41%
Previous 0.39%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$262.75 - $319.31 $226,227 - $274,925
861 Added 6.79%
13,538 $4.23 Million
Q1 2024

May 01, 2024

BUY
$268.87 - $324.56 $148,685 - $179,481
553 Added 4.56%
12,677 $3.6 Million
Q4 2023

Feb 12, 2024

BUY
$255.7 - $288.46 $227,061 - $256,152
888 Added 7.9%
12,124 $3.49 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $3,717 - $4,614
-17 Reduced 0.15%
11,236 $3.02 Million
Q2 2023

Aug 11, 2023

BUY
$214.27 - $253.37 $187,057 - $221,192
873 Added 8.41%
11,253 $2.5 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $2.34 Million - $2.86 Million
10,380 New
10,380 $2.51 Million
Q3 2022

Nov 08, 2022

BUY
$224.46 - $253.15 $263,067 - $296,691
1,172 Added 14.89%
9,044 $2.04 Million
Q2 2022

Jul 27, 2022

BUY
$230.71 - $256.74 $1.82 Million - $2.02 Million
7,872 New
7,872 $1.92 Million
Q1 2022

May 11, 2022

SELL
$219.27 - $242.57 $928,827 - $1.03 Million
-4,236 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$198.88 - $227.6 $52,703 - $60,314
265 Added 6.67%
4,236 $953,000
Q3 2021

Oct 20, 2021

SELL
$212.27 - $248.7 $32,477 - $38,051
-153 Reduced 3.71%
3,971 $844,000
Q2 2021

Aug 06, 2021

SELL
$233.58 - $259.14 $117,490 - $130,347
-503 Reduced 10.87%
4,124 $1.01 Million
Q1 2021

Jun 23, 2021

SELL
$221.91 - $258.6 $44,382 - $51,720
-200 Reduced 4.14%
4,627 $1.15 Million
Q4 2020

Feb 03, 2021

BUY
$216.38 - $257.67 $50,849 - $60,552
235 Added 5.12%
4,827 $1.11 Million
Q3 2020

Nov 12, 2020

BUY
$234.65 - $260.95 $75,557 - $84,025
322 Added 7.54%
4,592 $1.17 Million
Q2 2020

Aug 12, 2020

SELL
$197.81 - $242.74 $22,550 - $27,672
-114 Reduced 2.6%
4,270 $1.01 Million
Q1 2020

Apr 30, 2020

SELL
$182.24 - $241.7 $13,121 - $17,402
-72 Reduced 1.62%
4,384 $888,000
Q4 2019

Jan 24, 2020

BUY
$189.21 - $243.2 $39,166 - $50,342
207 Added 4.87%
4,456 $1.07 Million
Q3 2019

Nov 12, 2019

BUY
$174.11 - $208.62 $106,729 - $127,884
613 Added 16.86%
4,249 $822,000
Q2 2019

Jul 17, 2019

BUY
$166.7 - $195.41 $605,454 - $709,729
3,632 Added 90800.0%
3,636 $670,000
Q2 2019

Jul 12, 2019

SELL
$166.7 - $195.41 $565,279 - $662,635
-3,391 Reduced 99.88%
4 $0
Q1 2019

Apr 05, 2019

BUY
$180.87 - $203.88 $50,824 - $57,290
281 Added 9.02%
3,395 $0
Q4 2018

Jan 15, 2019

BUY
$178.4 - $208.25 $7,136 - $8,330
40 Added 1.3%
3,114 $606,000
Q3 2018

Oct 03, 2018

BUY
$185.29 - $208.89 $94,683 - $106,742
511 Added 19.94%
3,074 $0
Q2 2018

Jul 23, 2018

SELL
$166.05 - $186.51 $13,450 - $15,107
-81 Reduced 3.06%
2,563 $473,000
Q1 2018

Apr 19, 2018

BUY
$169.43 - $198.0 $122,159 - $142,758
721 Added 37.49%
2,644 $0
Q4 2017

Feb 09, 2018

SELL
$168.79 - $188.59 $1,856 - $2,074
-11 Reduced 0.57%
1,923 $334,000
Q3 2017

Nov 13, 2017

SELL
$167.29 - $191.0 $1.4 Million - $1.59 Million
-8,339 Reduced 81.17%
1,934 $0
Q2 2017

Aug 31, 2017

BUY
N/A
10,273
10,273 $1.77 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Stone X Group Inc. Portfolio

Follow Stone X Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.